Comparison of postoperative complications in advanced head and neck cancer patients receiving neoadjuvant chemotherapy followed by surgery versus surgery alone

被引:3
|
作者
Joshi, Poonam [1 ]
Joshi, Amit [2 ]
Prabhash, Kumar [2 ]
Noronha, Vanita [2 ]
Chaturvedi, Pankaj [1 ]
机构
[1] Tata Mem Hosp, Dept Head & Neck Surg, Bombay, Maharashtra, India
[2] Tata Mem Hosp, Dept Med Oncol, Bombay, Maharashtra, India
关键词
Complications; head and neck cancer; neoadjuvant chemotherapy; surgery;
D O I
10.4103/0971-5851.171548
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Head and neck cancer is the third most common cancer in India with 60% presenting in advanced stages. There is the emerging role of neoadjuvant chemotherapy (NACT) in the management of these advanced cancers. There is a general perception that complication rates are higher with the use of NACT. Materials and Methods: This is a retrospectively collected data of head and neck cancer patients operated at our hospital from March 2013 to September 2014. A total of 205 patients were included in the study. These patients were studied in two groups. Group 1 included 153 patients who underwent surgery alone, and Group 2 included 52 patients who received 2-3 cycles of NACT followed by surgery. Results: The mean age of the population was 51 years in the Group 1 and 45 years in Group 2. The hospital stay and readmissions in postoperative period were similar in the two groups. In this study, the complication rate was 37.9% in the surgery patients and 30.8% in the NACT patients (P = 0.424). Conclusion: The postoperative complication rates in patients who received NACT followed by surgery were not significantly different from those who underwent surgery.
引用
收藏
页码:249 / 254
页数:6
相关论文
共 50 条
  • [31] Impact of neoadjuvant chemotherapy on perioperative morbidity after major surgery for head and neck cancer
    Kiong, Kimberley L.
    Lin, Fang-Yu
    Yao, Christopher M. K. L.
    Guo, Theresa
    Ferrarotto, Renata
    Weber, Randal S.
    Lewis, Carol M.
    CANCER, 2020, 126 (19) : 4304 - 4314
  • [32] Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer
    Lin, Yan
    Wang, Shou-Feng
    Liang, Huan-Wei
    Liu, Yang
    Huang, Wei
    Pan, Xin-Bin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [33] Induction chemotherapy before surgery for unresectable head and neck cancer
    Schmaltz, H.
    Borel, C.
    Ciftci, S.
    Takeda-Raguin, C.
    Debry, C.
    Schultz, P.
    Dupret-Bories, A.
    B-ENT, 2016, 12 (01): : 29 - 32
  • [34] Neoadjuvant chemotherapy followed by surgery in lung cancer: Indian scenario
    Kumar, Sunil
    Saikia, Jyoutishman
    Kumar, Vinay, Jr.
    Malik, Prabhat S.
    Madan, Karan
    Jain, Deepali
    Bharati, Sachidanand
    CURRENT PROBLEMS IN CANCER, 2020, 44 (03)
  • [35] Paclitaxel Plus Platinum Neoadjuvant Chemotherapy Followed by Surgery Versus Primary Surgery in Locally Advanced Cervical Cancer-A Propensity Score Matching Analysis
    Zhang, Yanan
    Li, Bin
    Wang, Yating
    Liu, Shuanghuan
    Wang, Haibo
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [36] Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications
    Eto, Kojiro
    Hiki, Naoki
    Kumagai, Koshi
    Shoji, Yoshiaki
    Tsuda, Yasuo
    Kano, Yosuke
    Yasufuku, Itaru
    Okumura, Yasuhiro
    Tsujiura, Masahiro
    Ida, Satoshi
    Nunobe, Souya
    Ohashi, Manabu
    Sano, Takeshi
    Yamaguchi, Toshiharu
    GASTRIC CANCER, 2018, 21 (04) : 703 - 709
  • [37] Liver Disease in Patients Undergoing Head and Neck Surgery: Incidence and Risk for Postoperative Complications
    Cramer, John D.
    Patel, Urjeet A.
    Samant, Sandeep
    Yang, Amy
    Smith, Stephanie Shintani
    LARYNGOSCOPE, 2017, 127 (01) : 102 - 109
  • [38] Induction chemotherapy followed by surgery for advanced oesophageal cancer
    Toxopeus, E. L. A.
    Talman, S.
    van der Gaast, A.
    Spaander, V. M. C. W.
    van Rij, C. M.
    Krak, N. C.
    Biermann, K.
    Tilanus, H. W.
    Mathijssen, R. H. J.
    van Lanschot, J. J. B.
    Wijnhoven, B. P. L.
    EJSO, 2015, 41 (03): : 323 - 332
  • [39] Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer
    Poonawalla, Insiya B.
    Lairson, David R.
    Chan, Wenyaw
    Piller, Linda B.
    Du, Xianglin L.
    VALUE IN HEALTH, 2015, 18 (04) : 387 - 395
  • [40] Clinical Outcome of Iranian Patients with Advanced Ovarian Cancer with Neoadjuvant Chemotherapy versus Primary Debulking Surgery
    Ghaemmaghami, Fatemeh
    Karimi-Zarchi, Mojgan
    Modares-Gilani, Mitra
    Mousavi, Azamsadat
    Behtash, Nadereh
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008, 9 (04) : 719 - 724